CLinical experience acquired with the efalizumab (Raptiva®) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial
Title:
CLinical experience acquired with the efalizumab (Raptiva®) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial
Author:
Dubertret, L. Sterry, W. Bos, J.D. Chimenti, S. Shumack, S. Larsen, C.G. Shear, N.H. Papp, K.A.